Developing the Next Generation Of Immunotherapy To Combat Cancer

Targeting ENPP1: The Only Known Checkpoint In Innate Immunity

  • Activation of the cGAS-STING pathway begins by recognition of cytoplasmic dsDNA by cGAS which then generates the natural ligand of STING, 2’3’ cGAMP

  • ENPP1 negatively regulates this pathway by breaking down 2’3’ cGAMP into AMP and GMP

  • AMP can be converted by CD73 into Adenosine, a key immune suppressive molecule in the tumor microenvironment

  • ENPP1 is highly upregulated as tumors becomes metastatic

  • High levels of ENPP1 have been correlated with:

    • Reduced immune infiltration

    • Increased metastasis

    • Tumor resistance to chemotherapy and adaptive immunotherapies

Key ENPP1 Literature

Presentations

AACR 2020

AACR 2023

AACR 2024